Solventum
SOLV
85.88
-1.16
-1.33%
Solventum
US · SOLV
#1124 by market cap
Listed 2024
85.88
-1.16
-1.33%
Live - 5344 symbols - heartbeat 162s ago
· 2026-10-08 07:41
Pre-market
85.88
0.00%
After-hours
85.88
0.00%
- Market cap
- 14.62B
- P/E (TTM)i
- 10.50
- P/Bi
- 3.05
- EPSi
- 8.88
- Div yieldi
- 0.00%
- 52W posi
- 74%
Reader sentiment
Are you bullish or bearish on SOLV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 93.01% 0.00pp
- Institutions
- 1,033 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund60.59%
Public Company17.69%
Hedge Fund9.50%
Private Company2.67%
Government Pension Fund1.02%
Sovereign Wealth Fund1.01%
Family Office/Trust0.27%
Individual/Insider0.26%
Insurance Company0.15%
Other6.85%
Top holders as of 2026-03-19
3M Company
15.02% · 25.57M sh
Independent Franchise Partners, LLP
9.50% · 16.17M sh
Vanguard Capital Management, LLC
6.14% · 10.45M sh
BlackRock
5.73% · 9.76M sh
Trian Fund Management, L.P.
4.84% · 8.24M sh
Vanguard Portfolio Management, LLC
3.72% · 6.33M sh
Davis Selected Advisers LP
3.71% · 6.31M sh
State Street Global Advisors
3.31% · 5.64M sh
Geode Capital Management, LLC
2.88% · 4.91M sh
Boston Partners Global Investors, Inc.
2.37% · 4.04M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 42 buys · 8 sells
| Name | Role | Stake |
|---|---|---|
| 3M Company | -- | 15.02% |
| Bryan Hanson | Chief Executive Officer | 0.11% |
| Wayde McMillan | Chief Financial Officer | 0.03% |
| Amy Landucci | Chief Information & Digital Officer | 0.02% |
| Paul Harrington | Chief Supply Chain Officer | 0.01% |
| Carrie Cox | Director | 0.01% |
| Marcela Kirberger | Chief Legal Affairs Officer & Corporate Secretary | 0.01% |
| Tammy Gomez | Chief Human Resources Officer | 0.01% |
| Amy McBride-Wendell | Director | 0.01% |
| James Barry | Executive VP & Group President of Medical Surgical | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-31 | Bryan Hanson | Chief Executive Officer | Derivative Exercise and Sale | -26,468 | $90.95 |
| 2026-08-31 | Bryan Hanson | Chief Executive Officer | Derivative Exercise and Retained | +40,793 | -- |
| 2026-08-16 | Neil Zieselman | Chief Accounting Officer | Other Derivative Acquisition | +6,911 | -- |
| 2026-05-14 | Carrie Cox | Director | Other Derivative Acquisition | +4,848 | -- |
| 2026-05-14 | John Weiland | Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Karen May | Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Amy McBride-Wendell | Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Glenn Eisenberg | Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Bernard Harris | Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Susan DeVore | Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Carlos Alban | Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Darryl Wilson | Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Elizabeth Mily | Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Shirley Edwards | Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-12 | Wayde McMillan | Chief Financial Officer | Derivative Exercise and Sale | -4,404 | $74.41 |
| 2026-05-12 | Wayde McMillan | Chief Financial Officer | Derivative Exercise and Retained | +5,099 | -- |
| 2026-05-12 | Bryan Hanson | Chief Executive Officer | Derivative Exercise and Sale | -13,503 | $74.41 |
| 2026-05-12 | Bryan Hanson | Chief Executive Officer | Derivative Exercise and Retained | +20,812 | -- |
| 2026-05-12 | Marcela Kirberger | Chief Legal Affairs Officer & Corporate Secretary | Derivative Exercise and Sale | -1,952 | $74.41 |
| 2026-05-12 | Marcela Kirberger | Chief Legal Affairs Officer & Corporate Secretary | Derivative Exercise and Retained | +2,536 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:41:38 · For reference only, not investment advice and not tailored to your situation.